Manzo Pablo Gabriel, Martín Sandra, Uema Sonia, Charles Germán, Montero Bruni Felipe, Núñez Montoya Susana, Bertotto María Eugenia, Eynard Martín, Armando Pedro, Bustos Fierro Carolina
Universidad Nacional de Córdoba, Facultad de Ciencias Químicas, Centro de Química Aplicada (Cequimap). Córdoba, Argentina. .
Universidad Nacional de Córdoba, Facultad de Ciencias Químicas, Departamento de Química Orgánica. Córdoba, Argentina..
Rev Fac Cien Med Univ Nac Cordoba. 2022 Jun 6;79(2):123-131. doi: 10.31053/1853.0605.v79.n2.30922.
The therapeutic use of the “cannabis” oil is a social problem that puts legal, health, scientific and cultural aspects under stress. Difficulty in access generates an emptiness exploited by the illegal market, to which patients and relatives resort to improve their health and quality of life. These oils, with unknown chemical composition, are used without therapeutic follow-up. An interdisciplinary team from the Universidad Nacional de Córdoba (UNC) started the study of this problem with the aim of characterizing the socio-therapeutic use of “cannabis" oil in Córdoba and establishing a relationship with the real content of cannabinoids.
Observational-descriptive and cross-sectional study approved by the Comité Institucional de Ética de las Investigaciones en Salud, Hospital Nacional de Clínicas from UNC (CIEIS-HNC-UNC): interviews with patients/caregivers of legal age who used the “cannabis” oil (year 2019). Experimental study: analysis of oil samples obtained from interviewees to determine their cannabinoid content, specifically delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), by High Performance Liquid Chromatography analysis (HPLC).
thirty-seven interviews were conducted, and 48 samples were analysed. The 73% were adults and older adults. The 92% started using the oil without prescription or medical suggestion, mainly due to the lack of effectiveness of other therapies (54%) and in the search for therapeutic alternatives (33%). The 84% perceived it to be effective (moderate to highly effective), and 78% reported no adverse events. Main uses: refractory epilepsy 27% and arthritis/arthrosis 24%. Fifteen percent of the samples showed no quantifiable content of CBD and THC, and 67% had only THC. The quantifiable content of cannabinoids was very low.
This work allowed carrying out a preliminary information-gathering on several aspects (social and therapeutic) about the use of “cannabis” oil in Córdoba, and to analyze the chemical quality of the oils consumed. An important finding was the discrepancy between the effectiveness perceived by users and the low cannabinoid content detected.
“大麻”油的治疗用途是一个社会问题,给法律、健康、科学和文化等方面带来了压力。获取困难导致非法市场趁虚而入,患者及其亲属会求助于非法市场以改善健康状况和生活质量。这些化学成分不明的油类在没有治疗跟进的情况下被使用。科尔多瓦国立大学(UNC)的一个跨学科团队开始研究这个问题,目的是描述科尔多瓦“大麻”油的社会治疗用途,并建立与大麻素实际含量的关系。
由UNC国立临床医院健康研究伦理机构委员会(CIEIS - HNC - UNC)批准的观察性描述性横断面研究:对2019年使用“大麻”油的法定年龄患者/护理人员进行访谈。实验研究:对从受访者处获得的油样进行分析,通过高效液相色谱分析(HPLC)确定其大麻素含量,特别是Δ-9-四氢大麻酚(THC)和大麻二酚(CBD)。
进行了37次访谈,分析了48个样本。73%为成年人及老年人。92%的人在没有处方或医疗建议的情况下开始使用该油,主要原因是其他疗法缺乏疗效(54%)以及寻求治疗替代方案(33%)。84%的人认为其有效(中度至高度有效),78%的人报告无不良事件。主要用途:难治性癫痫占27%,关节炎/关节病占24%。15%的样本显示CBD和THC含量不可量化,67%的样本仅含有THC。大麻素的可量化含量非常低。
这项工作使得能够就科尔多瓦“大麻”油使用的几个方面(社会和治疗)进行初步信息收集,并分析所消费油类的化学质量。一个重要发现是使用者感知的有效性与检测到的低大麻素含量之间存在差异。